Breakthrough Designation: Drugmakers Cheer 'Speed Lane' For FDA Approval
In the 1990s, she said, the agency was not seeing drugs whose promise could be detected in early clinical trials. J&J's ibrutinib
breakthrough designation drugmakers cheer speed lane fda approval s say agency see drug promise detect early clinical trial jj ibrutinib